Status:
COMPLETED
Psychiatric Phenotype Characterization of Individuals With FOXP1 Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
FOXP1 Syndrome
Eligibility:
All Genders
Brief Summary
FOXP1 syndrome is a rare genetic disorder with a variable phenotype, characterized somatically by facial dysmorphia, dysphagia, hypotonia, relative or real macrocephaly, which may be associated with c...
Detailed Description
FOXP1 syndrome is a rare genetic pathology disorder with a variable phenotype, characterized somatically by facial dysmorphia, dysphagia, hypotonia, relative to or real macrocephaly, which may be asso...
Eligibility Criteria
Inclusion
- Minor or adult patient, without age limit, presenting with FOXP1 syndrome due to an identified genetic anomaly affecting the FOXP1 gene;
- Patient who has sought consultationat Necker-Enfants Malades hospital;
- Legal guardians of the minor patient or legal representative of the adult patient, and the minor or adult patient capable of providing consent to participate in the study, informed about the study and not objecting to participation in the study.
Exclusion
- Non French-speaking legal guardians or legal representatives of the patient;
- Illiterate legal guardians or legal representatives of the patient.
Key Trial Info
Start Date :
January 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06211673
Start Date
January 19 2024
End Date
July 16 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015